Publication:
Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System

dc.contributor.authorSánchez-Hernández, Sabina
dc.contributor.authorAguilar-González, Araceli
dc.contributor.authorGuijarro-Albaladejo, Beatriz
dc.contributor.authorMaldonado-Pérez, Noelia
dc.contributor.authorRamos-Hernández, Iris
dc.contributor.authorCortijo-Gutiérrez, Marina
dc.contributor.authorSánchez Martín, Rosario María
dc.contributor.authorBenabdellah, Karim
dc.contributor.authorMartin, Francisco
dc.contributor.authoraffiliation[Sánchez-Hernández,S; Aguilar-González,A; Guijarro-Albaladejo,B; Maldonado-Pérez,N; Ramos-Hernández,I; Cortijo-Gutiérrez,M; Benabdellah,K; Martin,F] Genomic Medicine Department, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain. [Aguilar-González,A; Sánchez Martín,RM] Department of Medicinal & Organic Chemistry and Excellence Research Unit of “Chemistry Applied to Biomedicine and the Environment”, Faculty of Pharmacy, University of Granada, Granada, Spain.
dc.contributor.funderThis study was funded by the Spanish ISCIII Health Research Fund and the European Regional Development Fund (FEDER) through research grants PI15/02015, PI18/00337 (F.M.) and PI18/00330 (K.B.) The CECEyU and CSyF of the Junta de Andalucía EDER/European Cohesion Fund (FSE) for Andalusia provided the following research grants: 2016000073391-TRA, 2016000073332-TRA, PI-57069, CARTPI-0001-201 and PAIDI-Bio326 (F.M.) and PI-0014-2016 (K.B). K.B. held a Nicolas Monardes regional Ministry of Health contract (0006/2018). S.S.H is funded thanks to Fundación Poco Frecuente donations. A.A.-G. and N.M.-P. are funded by Spanish Ministry of Science and Innovation (SMSI) through fellowships FPU17/04327 and FPU17/02268 respectively. I.R.H is funded by the ISCIII through a PFIS fellowship (FI19/00163). M.C.-G. is funded by (SMSI) through fellowship GJ (PEJ-2018-001760-A).
dc.date.accessioned2022-08-04T10:10:25Z
dc.date.available2022-08-04T10:10:25Z
dc.date.issued2020-06-18
dc.description.abstractIn spite of the enormous potential of CRISPR/Cas in basic and applied science, the levels of undesired genomic modifications cells still remain mostly unknown and controversial. Nowadays, the efficiency and specificity of the cuts generated by CRISPR/Cas is the main concern. However, there are also other potential drawbacks when DNA donors are used for gene repair or gene knock-ins. These GE strategies should take into account not only the specificity of the nucleases, but also the fidelity of the DNA donor to carry out their function. The current methods to quantify the fidelity of DNA donor are costly and lack sensitivity to detect illegitimate DNA donor integrations. In this work, we have engineered two reporter cell lines (K562_SEWAS84 and K562GWP) that efficiently quantify both the on-target and the illegitimate DNA donor integrations in a WAS-locus targeting setting. K562_SEWAS84 cells allow the detection of both HDR-and HITI-based donor integration, while K562GWP cells only report HDR-based GE. To the best of our knowledge, these are the first reporter systems that allow the use of gRNAs targeting a relevant locus to measure efficacy and specificity of DNA donor-based GE strategies. By using these models, we have found that the specificity of HDR is independent of the delivery method and that the insertion of the target sequence into the DNA donor enhances efficiency but do not affect specificity. Finally, we have also shown that the higher the number of the target sites is, the higher the specificity and efficacy of GE will be.es_ES
dc.description.versionYeses_ES
dc.identifier.citationSánchez-Hernández S, Aguilar-González A, Guijarro-Albaladejo B, Maldonado-Pérez N, Ramos-Hernández I, Cortijo-Gutiérrez M, et al.Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System. Cells. 2020 Jun 18;9(6):1492es_ES
dc.identifier.doi10.3390/cells9061492es_ES
dc.identifier.essn2073-4409
dc.identifier.pmcPMC7349026
dc.identifier.pmid32570971es_ES
dc.identifier.urihttp://hdl.handle.net/10668/3877
dc.journal.titleCells
dc.language.isoen
dc.page.number17 p.
dc.publisherMDPIes_ES
dc.relation.publisherversionhttps://www.mdpi.com/2073-4409/9/6/1492/htmes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.accessRightsAcceso abiertoes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectModelses_ES
dc.subjectDNA donores_ES
dc.subjectOn-target integrationes_ES
dc.subjectHomologous directed recombination (HDR)es_ES
dc.subjectEfficacyes_ES
dc.subjectSafetyes_ES
dc.subjectSpecificityes_ES
dc.subjecteGFPes_ES
dc.subjectdsREDes_ES
dc.subjectCRISPR/Cas9es_ES
dc.subjectModelos estructuraleses_ES
dc.subjectReparación del ADN por recombinaciónes_ES
dc.subjectEficaciaes_ES
dc.subjectSeguridades_ES
dc.subjectEspecificidades_ES
dc.subjectProteínas fluorescentes verdeses_ES
dc.subjectProteína 9 asociada a CRISPRes_ES
dc.subjectADN recombinantees_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::DNA::DNA, Recombinantes_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Gene Targetinges_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Genes, Reporteres_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Genetic Engineeringes_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Biological Therapy::Genetic Therapyes_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genetic Vectorses_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.subject.meshMedical Subject Headings::Anatomy::Cells::Cells, Cultured::Cell Line::Cell Line, Tumor::K562 Cellses_ES
dc.subject.meshMedical Subject Headings::Organisms::Viruses::RNA Viruses::Retroviridae::Lentiviruses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Macromolecular Substances::Polymers::Biopolymers::Microfilament Proteins::Wiskott-Aldrich Syndrome Protein Family::Wiskott-Aldrich Syndrome Proteines_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Epigenesis, Genetic::Gene Silencing::CRISPR-Cas Systemses_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Recombination, Genetic::Homologous Recombinationes_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Theoretical::Models, Biological::Models, Genetices_ES
dc.titleDevelopment of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 Systemes_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
SanchezHernandez_DevelopmentOf.pdf
Size:
2.35 MB
Format:
Adobe Portable Document Format
Description:
Artículo original
Loading...
Thumbnail Image
Name:
SanchezHernandez_DevelopmentOf_MaterialSuplementario.pdf
Size:
551.19 KB
Format:
Adobe Portable Document Format
Description:
Material suplementario